Results 201 to 210 of about 57,670 (308)

The Clinical Utility of 3D Electroanatomical Mapping for Atrial Fibrillation Ablation by Pulsed Field Ablation

Journal of Arrhythmia, Volume 41, Issue 6, December 2025.
Systematic high‐density 3D electroanatomical remapping during pulsed field ablation detected residual conduction in 9% of cases, predominantly in the right superior pulmonary vein. Detailed voltage analysis demonstrated sharp 1 mm lesion borders, highlighting the value of 3D mapping for assessing lesion integrity and procedural endpoints in pulsed ...
Robert N. Kerley, David Keane
wiley   +1 more source

Addition of Atrial Myopathy to HATCH Score for Predicting New-Onset Atrial Fibrillation After Ablation of Atrial Flutter. [PDF]

Pacing Clin Electrophysiol
Nantsupawat T, Li Y, Li S, Sathnur N, Chesdachai S, Adabag S, Benditt DG, Tholakanahalli VN.   +7 more
europepmc   +1 more source

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1192-1201, December 2025.
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj, Paul Kwo, Stephen Chris Pappas, Jacqueline G. O'Leary, Khurram Jamil, Sanaz Cardoza, Florence Wong   +6 more
wiley   +1 more source

Atrial Fibrillation and Atrial Flutter Detection Using Deep Learning. [PDF]

Sensors (Basel)
Kraft D, Rumm P.
europepmc   +1 more source

Between- and within-site variation in medication choices and adverse events during procedural sedation for electrical cardioversion of atrial fibrillation and flutter [PDF]

, 2017
David Clinkard, Ian G. Stiell, Eddy Lang, Stuart Rose, Catherine M. Clement, Robert J. Brison, Brian H. Rowe, Bjug Borgundvaag, Trevor Langhan, Kirk Magee, Rob Stenstrom, Jeffrey J. Perry, David H. Birnie, George A. Wells, Andrew D. McRae   +14 more
openalex   +1 more source

The Clinicopathologic Spectrum of Rosai–Dorfman–Destombes Disease in Adults: An Analysis of 16 Cases

European Journal of Haematology, Volume 115, Issue 6, Page 555-564, December 2025.
ABSTRACT Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytic proliferation with protean clinical manifestations, resulting from the accumulation of activated histiocytes within nodal and extra‐nodal tissues. The diagnosis can be missed, particularly when biopsies are obtained from extra‐nodal sites, where histological features may be less ...
Mark Trinder, Collin Pryma, Emily Leung, Graham W. Slack, Pedro Farinha, Sean Young, Neval Ozkaya, Mollie Carruthers, Luke Y. C. Chen   +8 more
wiley   +1 more source

Prevalence and incidence of atrial fibrillation and atrial flutter: results of the population-based Heinz Nixdorf Recall study. [PDF]

Open Heart
Schramm S, Schlechter P, Reiberg A, Klauser P, Erbel R, Schmidt B, Stang A.   +6 more
europepmc   +1 more source

Markers of Giant Cell Arteritis in Patients Presenting With Ischemic Stroke: A Scoping Review

European Journal of Neurology, Volume 32, Issue 12, December 2025.
Giant cell arteritis should be considered in patients aged ≥ 50 years presenting with vertebrobasilar ischemic events, multifocal infarcts affecting both vertebrobasilar and carotid territories, or recurrent ischemic events despite optimal secondary prevention.
Alain‐Mauricio Vergara, Marco Perez‐Caceres, Maxime Chayer‐Lanthier, Carolyn Ross, Jean‐Paul Makhzoum, Sylvain Lanthier   +5 more
wiley   +1 more source

Atrial flutter with 1:1 conduction [PDF]

, 2002
Jian-cheng Tan
openalex   +1 more source

Impact of Direct Oral Anticoagulant Uptake on Hospitalizations for Stroke/Transient Ischemic Attack, Intracranial Hemorrhage, and Gastrointestinal Bleeding in Individuals With Atrial Fibrillation: A Population‐Based Study

Fundamental &Clinical Pharmacology, Volume 39, Issue 6, December 2025.
ABSTRACT Background Direct‐acting oral anticoagulants (DOACs) have largely replaced warfarin for stroke prevention in patients with atrial fibrillation, yet their population‐level impact on health outcomes and costs remains unclear. We examined whether the widespread uptake of DOACs was associated with changes in hospitalization rates and costs for ...
Tony Antoniou, Daniel McCormack, Tianru Wang, Mina Tadrous, Tara Gomes   +4 more
wiley   +1 more source